NewslettersMammary Cell NewsUncategorizedSELENOF Is a New Tumor Suppressor in Breast CancerBy Justin.choi - January 27, 202208Restoring SELENOF could attenuate a number of aggressive cancer phenotypes in breast cancer cells, including clonogenic survival, and enhance the response to drugs or radiation used in breast cancer therapy.[Oncogene] 6445212 AAAAAAAA items 1 apa 0 default asc 1 171193 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract